Drug Trial Radar · NCT03537508
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
Last checked: Nov 20, 2026Latest source record: Oct 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,627
Actual
Start
Apr 25, 2018
Primary completion
Sep 22, 2023
Study completion Sep 22, 2023
Sponsor
- Lead sponsor
- Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- May 25, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 42 days, up to 89 days
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study was to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO® when both are administered concomitantly with routine pediatric vaccines to healthy infants and toddlers in the US.
Conditions
- Healthy Volunteers (Meningococcal Infection)
Interventions
MenACYW conjugate vaccineBiological
Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine 0.5 mL, intramuscular
MenACYW-135 conjugate vaccineBiological
Meningococcal (Groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine, 0.5 mL, intramuscular
DTaP-IPV//Hib vaccineBiological
DTaP-IPV//Hib vaccine at 2, 4, 6 and 12 to 15 (Group 1a)/15-18 (Group 1b and Group 2) months of age Intramuscular
Pneumococcal 13-valent conjugate vaccineBiological
Pneumococcal vaccine at 2, 4, 6, and 12 months of age, Intramuscular
Pentavalent rotavirus vaccineBiological
Rotavirus vaccine at 2, 4, and 6 months of age, oral solution
Hepatitis B vaccineBiological
Hepatitis B vaccine at 2 and 6 months of age, Intramuscular
Measles, mumps, rubella (MMR) vaccineBiological
MMR vaccine at 12 months of age, Subcutaneous
Varicella vaccineBiological
Varicella vaccine at 12 months of age
Hepatitis A vaccineBiological
Hepatitis A vaccine at 15 to 18 months of age
Primary outcomes
What the sponsor says the trial is designed to measure.
- Groups 1a and 2a: Percentage of Participants With Vaccine Seroresponse Measured by Serum Bactericidal Assay Using Human Complement (hSBA) at Day 30 Post 12-Month VaccinationTime frame: Day 30 post 12-month vaccination (Month 13)
- Groups 1 and 2: Percentage of Participants Who Achieved Antibody Titers >=1:8 by hSBA at Day 30 Post 6-Month VaccinationTime frame: Day 30 post 6-month vaccination (Month 7)
Locations
70 sites in 2 countries. Site status is shown where the registry gives one.
Birmingham Pediatric Associates Site Number : 8400026
Birmingham, Alabama
Southeastern Pediatric Associates Site Number : 8400003
Dothan, Alabama
MedPharmics, LLC - Phoenix Site Number : 8400083
Phoenix, Arizona
Northwest Arkansas Pediatric Clinic Site Number : 8400011
Fayetteville, Arkansas
The Children's Clinic of Jonesboro, PA Site Number : 8400032
Jonesboro, Arkansas
Emmaus Research Center, Inc Site Number : 8400031
Anaheim, California
Premier Health Research Center Site Number : 8400007
Downey, California
Joint Clinical Trials Huntington Park Site Number : 8400126
Huntington Park, California
United Clinical Research Site Number : 8400092
Huntington Park, California
Matrix Clinical Research Site Number : 8400095
Los Angeles, California
Center for Clinical Trials, LLC Site Number : 8400030
Paramount, California
Center for Clinical Trials of San Gabriel Site Number : 8400076
West Covina, California
Asclepes Research Centers Site Number : 8400064
Brooksville, Florida
Avail Clinical Research Site Number : 8400077
DeLand, Florida
Next Phase Research Alliance Site Number : 8400057
Hialeah, Florida
Homestead Medical Clinic, P.A. Site Number : 8400014
Homestead, Florida
Next Phase Research Alliance Site Number : 8400040
Homestead, Florida
Children's Research, LLC Site Number : 8400063
Lake Mary, Florida
Axcess Medical Research Site Number : 8400068
Loxahatchee Groves, Florida
Acevedo Clinical Research Associates Site Number : 8400001
Miami, Florida
Florida Hospital Medical Group Pediatrics Site Number : 8400108
Orlando, Florida
IMIC Inc Site Number : 8400022
Palmetto Bay, Florida
Jedidiah Clinical Research Site Number : 8400132
Tampa, Florida
Baybol Research Institute Site Number : 8400008
Chamblee, Georgia
Snake River Research, PLLC Site Number : 8400073
Idaho Falls, Idaho
Qualmedica Research, LLC Site Number : 8400106
Evansville, Indiana
Brownsboro Park Pediatrics Site Number : 8400010
Louisville, Kentucky
All Children Pediatrics Site Number : 8400043
Louisville, Kentucky
ACC Pediatric Reasearch Site Number : 8400023
Haughton, Louisiana
Velocity Clinical Research Site Number : 8400025
Metairie, Louisiana
LSUHSC-Shreveport Site Number : 8400120
Shreveport, Louisiana
University of Maryland at The Pediatric Center of Frederick Site Number : 8400004
Frederick, Maryland
Virgo-Carter Pediatrics Site Number : 8400041
Silver Spring, Maryland
MedPharmics Biloxi Site Number : 8400080
Biloxi, Mississippi
Craig Spiegel, MD Site Number : 8400037
Bridgeton, Missouri
Creighton University Site Number : 8400039
Omaha, Nebraska
Tiga Pediatrics Site Number : 8400137
New York, New York
Blue Pediatric & Adolescent Medicine Group Site Number : 8400100
Boone, North Carolina
Ohio Pediatric Research Site Number : 8400084
Dayton, Ohio
PriMed Clinical Research Site Number : 8400002
Dayton, Ohio
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.